Capital Observer
A diary of the thought process behind my investment decisions
Bought More Gilead
Looking at the price and volume in Genzyme it seems a deal is happening. I bought more Gilead. I am loaded to the gills with large cap biotech exposure.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment